ALKS Q1 2017 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$192M+22.3% YoY

Gross Profit

$151M78.9% margin

Operating Income

-$71M-37.0% margin

Net Income

-$69M-35.9% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

-10.2%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$23M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$513M

Stockholders' Equity

$1.2B

Cash & Equivalents

$181M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$192M	$157M	+22.3%
Gross Profit	$151M	$129M	+17.3%
Operating Income	-$71M	-$77M	+7.8%
Net Income	-$69M	-$77M	+11.0%